1 February 2025 in Journal of Thoracic Disease
Background: Chronic thromboembolic pulmonary hypertension (CTEPH), a progressive disease, can lead to decompensation of the right half of the heart and death. Studies on CTEPH have increased in number over the last two decades. This study aimed to perform a bibliometric analysis of the global scientific output on CTEPH in the last 24 years to identify research trends and hot topics. Methods: We searched the Web of Science Core Collection (WoSCC) Science Citation Index Expanded (Science Citation Index Expanded and Social Sciences Citation Index) for literature on CTEPH published from January 1, 2000 to January 31, 2024, and recorded their information. The Bibliometrix software package was used for bibliometric indicator analysis, and VOSviewer and CiteSpace were used to visualize trends and hotspots of CTEPH research. Results: Overall, 2,264 publications were included in the bibliometric analysis. The number of annual publications increased drastically from 14 in 2000 to 199 in 2023. The number of publications on CTEPH has increased over the last two decades, with 24.4% (n=553) of the publications published in top academic journals. The United States ranked first in publications and had the best CTEPH-investigating institutions; it also had the highest level of international cooperation. Distinctively, 7 of the top 10 institutions and 7 of the top 10 researchers in the field were from Europe with the most influential scientists. A relatively high percentage of the publications were published in top-rank academic journals, especially in respirology and cardiology journals. Pulmonary endarterectomy (PEA) was the main therapy during the first decade, while balloon pulmonary angioplasty (BPA) and pulmonary arterial hypertension (PAH)-targeted medicine have recently gained interest. Dual-energy computed tomography (DECT), right ventricular function, and the role of pulmonary endothelium in microvasculopathy have become the focus of CTEPH research. Conclusions: The number of publications on CTEPH has increased over the last two decades, and CTEPH has become a significant topic in both respirology and cardiology. Our results indicate that future research in this field will continue to focus on elucidating the pathophysiological mechanisms underlying this disorder, improving diagnostic accuracy, and developing novel imaging techniques. The integration of existing therapeutic modalities and the elucidation of right ventricular dysfunction are key areas of research.
22 November 2024 in Medicine
Colorectal cancer (CRC) is a major cause of cancer-related mortality worldwide. Urate, known for its antioxidant properties, may influence CRC risk and prognosis, but research on this is limited. We used Mendelian randomization (MR) analysis to explore the causal relationship between serum urate levels and CRC risk. Additionally, we analyzed National Health and Nutrition Examination Survey data to assess the impact of serum urate on CRC prognosis. MR analysis in the European population indicated that higher serum urate levels are associated with a reduced CRC risk (odds ratios [OR] inverse-variance weighted: 0.90, 95% CI: 0.81–0.99, P = .04; OR MR-Egger: 0.86, 95% CI: 0.75–0.98, P = .03; OR Weighted-Median: 0.85, 95% CI: 0.74–0.96, P = .01; OR Weighted-Mode: 0.83, 95% CI: 0.74–0.94, P = .002). Validation datasets supported this (OR inverse-variance weighted: 0.83, 95% CI: 0.72–0.96, P = .011). However, National Health and Nutrition Examination Survey data showed that higher serum urate levels are linked to poorer CRC outcomes (HR 1.50, 95% CI: 1.08–2.10, P = .02). This study suggests that elevated serum urate levels may reduce CRC risk but are associated with worse prognosis in CRC patients, highlighting its potential as a biomarker for CRC risk and prognosis.
22 March 2025 in International Journal of Infectious Diseases
Pseudomonas aeruginosa (P. aeruginosa) is an uncommon etiological agent in community-acquired pneumonia (CAP), typically associated with nosocomial or healthcare-associated infections, particularly in patients with underlying structural lung abnormalities or immunosuppression. P. aeruginosa is a ubiquitous gram-negative rod, widely distributed in the environment. However, CAP due to P. aeruginosa following soil ingestion is exceedingly rare. We present the case of a previously healthy 31-year-old patient, a middle school teacher, who developed CAP due to P. aeruginosa after ingesting garden soil for three consecutive days. The patient was admitted with symptoms including fever, chest pain, vomiting, and diarrhea. Chest computed tomography (CT) revealed two suspicious lesions in the left lower lobe, with one lesion exhibiting cavitation. Microbiological culture of bronchoalveolar lavage fluid (BALF) and stool confirmed the presence of P. aeruginosa infection. Subsequent antimicrobial susceptibility testing revealed that the P. aeruginosa isolate was pan-sensitive. Following 13 days of targeted antimicrobial therapy, the patient's symptoms and laboratory markers of infection improved significantly. A follow-up CT scan one month later demonstrated substantial resolution of the left lower lobe lesions, and the patient remained asymptomatic. This case, along with a review of related literature, suggests that geophagy may be a potential risk factor for P. aeruginosa infection. It underscores the importance of avoiding the consumption of unprocessed soil, which may be contaminated with pathogenic organisms.
29 June 2025 in Journal of Natural Medicines
4 December 2025 in Frontiers in Cardiovascular Medicine
We report a case of severe H1N1 influenza pneumonia complicated by intermediate-high risk pulmonary embolism (PE) in a 70-year-old male presenting with dyspnea and fever. Initial chest CT demonstrated bilateral interstitial infiltrates and a throat swab was positive for H1N1 on PCR. Despite aggressive antiviral, antibiotic, and respiratory support, the patient developed refractory hypoxemia with progressively elevated D-dimer levels. Subsequent CT pulmonary angiography confirmed the diagnosis of pulmonary embolism. As a rescue therapy, catheter-directed thrombolysis (CDT) was initiated under veno-arterial extracorporeal membrane oxygenation (ECMO) support. This intervention led to immediate hemodynamic and respiratory improvement, culminating in the patient's full recovery and discharge. This case highlights the critical need to suspect concomitant pulmonary embolism in severe pneumonia and demonstrates the therapeutic potential of ECMO-assisted CDT.
1 April 2026 in Journal of Thoracic Disease
Background: Bronchial artery embolization (BAE) is an established treatment for hemoptysis in bronchiectasis, yet the risk of post-procedural recurrence remains significant. This study aimed to investigate the clinical and hemodynamic predictors of hemoptysis recurrence in patients with bronchiectasis following BAE. Methods: We retrospectively analyzed 426 patients with bronchiectasis-related hemoptysis who underwent BAE between 2019 and 2022. Patients were followed for a median of 2 years to monitor recurrence. Baseline clinical data, angiographic findings, and hemodynamic parameters obtained via right heart catheterization were compared between recurrence and non-recurrence groups. Multivariate Cox proportional hazards regression was employed to identify independent risk factors for recurrence. Results: Among the 426 patients, 113 (26.53%) experienced recurrence during the follow-up period. The recurrence group exhibited more severe imaging findings, including a higher prevalence of multilobar involvement (≥3 lobes: 47.79% vs. 36.10%, P=0.03) and lung destruction (27.43% vs. 14.70%, P=0.003). Angiographically, the recurrence group had significantly more non-bronchial systemic artery (NBSA) branches and total embolized vessels (P<0.001). Hemodynamically, the recurrence group showed significantly higher mean pulmonary arterial pressure (mPAP), pulmonary vascular resistance (PVR), and total pulmonary resistance (TPR) (all P<0.05). Multivariate Cox regression identified the presence of systemic-to-pulmonary shunts (SPS) [hazard ratio (HR) =2.434; 95% confidence interval (CI): 1.173–5.049; P=0.02] and increased TPR (HR =1.123; 95% CI: 1.014–1.242; P=0.03) as independent predictors of recurrence. Conclusions: BAE is an effective intervention for hemoptysis in bronchiectasis, but recurrence is common. The presence of SPS and elevated TPR are key independent risk factors for post-BAE recurrence, highlighting the importance of hemodynamic assessment in predicting long-term outcomes.